Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C.
Males S, Gad RR, Esmat G, Abobakr H, Anwar M, Rekacewicz C, El Hoseiny M, Zalata K, Abdel-Hamid M, Bedossa P, Pol S, Mohamed MK, Fontanet A.
Males S, et al. Among authors: bedossa p.
Antivir Ther. 2007;12(5):797-803.
Antivir Ther. 2007.
PMID: 17713163
Clinical Trial.